Adheris, An InVentiv Health Company, Acquires Catalina Health To Become Nation's Largest Provider Of Patient Adherence Programs

Two Leaders in Medication Adherence and Education Join Forces to Deliver Tailored, Multi-Channel Communications Across the Continuum of Care to Millions of Patients Nationwide

inVentiv Health, offering best-in-class clinical, commercial and consulting services, announced recently that it has acquired Catalina Health, a subsidiary of Catalina Marketing, and combined the organization with Adheris, an inVentiv Health company.

With this acquisition, inVentiv Health’s Adheris becomes the nation’s largest provider of tailored, direct-to-patient medication adherence programs. Medication adherence programs, that include refill reminders and disease education, help millions of chronically ill people stay on their doctor-prescribed treatment, saving the healthcare system money and improving patient outcomes.

Both Adheris and Catalina Health work through pharmacies across the country to deliver adherence communications to millions of people. By joining forces, Adheris now has an unmatched reach through a network of more than 40 pharmacy partners composed of 30,000 pharmacies representing 65% of all retail prescriptions. Meanwhile, Adheris continues to rapidly grow its physician office network as a complement to its pharmacy network, allowing the company to reach even more patients with personalized communications across the continuum of care.

“Improving patient outcomes is our number one priority,” said Mark Dmytruk, President, inVentiv Health Patient Outcomes. “A coordinated adherence approach – reaching individual patients across multiple touch points with customized messages based on predictive analytics – improves adherence in ways other organizations simply cannot match.”

Adheris’ enhanced services will allow patients to receive communications in the doctor’s office from their trusted healthcare provider, followed by face-to-face communication with their pharmacist. Later, when it is time to refill their prescription, Adheris can send patients a message from their pharmacy reminding them of the importance of staying on the medication their doctor has prescribed. Communications can be delivered through multiple channels, including mobile.

By combining its expertise in predictive analytics with Catalina Health, Adheris will offer even stronger and more effective messaging based on a more robust understanding of consumer preferences and needs.  The acquisition also allows Adheris to provide clients with a single vendor for the purchase of multiple services, further streamlining the delivery of effective adherence communications.

Adherence programs have demonstrated value in improving individual health and saving the healthcare system money.  At a time when federal, state and private healthcare programs are seeking ways to reduce costs and improve care, adherence programs are increasingly important and further the goals of the Affordable Care Act. 

“Over the past year, we’ve seen growing client demand for coordinated patient messaging and an increased focus on patient-centric outcome strategies,” said Dmytruk.  “The acquisition improves our ability to deliver exactly what our clients need.”

Renee Selman, President of Catalina Health, will lead the combined business.  Prior to joining Catalina Health, Selman served in various leadership positions with Johnson & Johnson, including Worldwide President of Ethicon Women's Health and Urology.  Jim Rotsart will move from GM/Executive Vice President of Adheris to become EVP of inVentiv Health Patient Outcomes.

Catalina Health will now operate under the Adheris name.

About Adheris, Inc.
An inVentiv Health company, Adheris is the nation’s largest provider of tailored, direct-to-patient medication adherence programs. Medication adherence programs, that include refill reminders and disease education, help millions of chronically ill people stay on their doctor-prescribed treatment, improving patient outcomes. Adheris’ unmatched network, of more than 40 pharmacy partners composed of 30,000 pharmacies, represents 65% of all retail prescriptions. Its groundbreaking, multi-channel programs are HIPAA compliant and are proven to influence positive behavior change for millions of patients across the continuum of care. For more information, visit www.adheris.com.

About inVentiv Health
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to the life sciences industry. inVentiv offers convergent services that accelerate the performance of companies working to improve human life. In 40 countries around the world, inVentiv’s 12,000 employees work with more than 550 pharmaceutical, biotech and device companies, as well as companies that see health as a central part of their mission. inVentiv Health, Inc. is privately owned by inVentiv Group Holdings, Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team.  inVentiv Health helps clients transform promising ideas into commercial reality. For more information, visit http://www.inVentivHealth.com.